NOS1AP and Capon Associated Impaired Healing in Those with Diabetic Foot Ulcers

NOS1AP 和 Capon 与糖尿病足溃疡患者的愈合受损相关

基本信息

  • 批准号:
    9925084
  • 负责人:
  • 金额:
    $ 60.51万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-06-01 至 2022-05-31
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract Diabetes mellitus has reached epidemic proportions. A significant complication of diabetes is impaired healing which results in diabetic foot ulcer (DFU) and lower extremity amputation (LEA). About 20% of those with diabetes will develop a DFU. The annual incidence of LEA in Medicare beneficiaries with diabetes is about 4 per thousand, but rates of LEA can vary up to two- to threefold by race/ethnicity, geographic location, and gender. Individuals with diabetes develop DFU and LEA for many reasons that probably include interactions or alterations in intrinsic pathways responsible for wound repair, the presence of infection, changes to immune regulation, neuropathy, peripheral vascular disease, changes in anatomic function of the foot, and local trauma. DFUs are chronic wounds, which are by definition are wounds that have failed to follow an orderly and timely sequence resulting in healing and have impaired healing. Those that develop chronic wounds that result in LEA have wounds that heal slowly or not at all. Why a wound becomes chronic is not well understood. In the past 5 years, we have developed preliminary evidence showing that genetic variation in NOS1AP, which codes for a protein called capon, is associated with impaired healing of DFU, an increased risk of LEA, and decrease in the number or circulating endothelial precursors cells, which have been shown to be associated with individuals with a DFU that are less likely to heal. Our project focuses on producing further evidence to confirm the association of NOS1AP variation with impaired healing and to discern the functional basis of NOS1AP genetic variation on capon and ultimately capon’s influence on wound repair. To that end, the goal of our present study is to explore the possibility that common genetic variants of NOS1AP in those who have diabetes are associated with alterations in wound repair.
项目总结/摘要 糖尿病已达到流行病的程度。糖尿病的一个重要并发症是 导致糖尿病足溃疡(DFU)和下肢截肢(莱亚)的愈合。其中大约20% 糖尿病患者会出现DFU。在患有糖尿病的医疗保险受益人中,莱亚的年发病率约为 4/1000,但莱亚的比率可能因种族/民族、地理位置和 性别.糖尿病患者发生DFU和莱亚的原因有很多,可能包括相互作用或 负责伤口修复的内在途径的改变,感染的存在,免疫系统的变化, 调节、神经病变、外周血管疾病、足部解剖功能的变化以及局部 外伤DFU是慢性伤口,根据定义,其是未能遵循有序和 及时的序列导致愈合和受损的愈合。那些形成慢性伤口的人, 在莱亚中,伤口愈合缓慢或根本不愈合。为什么伤口会变成慢性的,我们还不太清楚。 在过去的5年里,我们已经开发了初步的证据表明,NOS 1AP的遗传变异, 编码一种叫做阉鸡的蛋白质,与DFU的愈合受损,莱亚的风险增加, 以及循环内皮前体细胞数量的减少,这已经被证明是 与不太可能治愈的DFU患者相关。我们的项目重点是进一步生产 证实NOS 1AP变异与愈合受损的关联以及辨别功能性 鸡NOS 1AP基因变异的基础以及鸡对创伤修复的影响。为此目的, 我们目前研究的目的是探索在这些人中NOS 1AP的常见遗传变异的可能性, 与伤口修复的改变有关。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David Margolis其他文献

David Margolis的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David Margolis', 18)}}的其他基金

A randomized, double-blind, multi-center comparative effectiveness study of spironolactone versus doxycycline hyclate for the treatment of acne in women
螺内酯与盐酸强力霉素治疗女性痤疮的随机、双盲、多中心比较疗效研究
  • 批准号:
    10296086
  • 财政年份:
    2021
  • 资助金额:
    $ 60.51万
  • 项目类别:
A randomized, double-blind, multi-center comparative effectiveness study of spironolactone versus doxycycline hyclate for the treatment of acne in women
螺内酯与盐酸强力霉素治疗女性痤疮的随机、双盲、多中心比较疗效研究
  • 批准号:
    10470869
  • 财政年份:
    2021
  • 资助金额:
    $ 60.51万
  • 项目类别:
Comparative effectiveness of spironolactone versus oral tetracycline-class antibiotics for the treatment of moderate to severe acne in women
螺内酯与口服四环素类抗生素治疗女性中度至重度痤疮的疗效比较
  • 批准号:
    9815052
  • 财政年份:
    2019
  • 资助金额:
    $ 60.51万
  • 项目类别:
African-Americans with Atopic Dermatitis: Skin Barrier and Immune
患有特应性皮炎的非裔美国人:皮肤屏障和免疫
  • 批准号:
    9228322
  • 财政年份:
    2016
  • 资助金额:
    $ 60.51万
  • 项目类别:
Data Sciences and Informatics
数据科学和信息学
  • 批准号:
    10477235
  • 财政年份:
    2016
  • 资助金额:
    $ 60.51万
  • 项目类别:
African-Americans with Atopic Dermatitis: Skin Barrier and Immune
患有特应性皮炎的非裔美国人:皮肤屏障和免疫
  • 批准号:
    9868281
  • 财政年份:
    2016
  • 资助金额:
    $ 60.51万
  • 项目类别:
Data Sciences and Informatics
数据科学和信息学
  • 批准号:
    10663986
  • 财政年份:
    2016
  • 资助金额:
    $ 60.51万
  • 项目类别:
Stem cell mobilization and diabetic skin ulcers
干细胞动员和糖尿病皮肤溃疡
  • 批准号:
    8538377
  • 财政年份:
    2012
  • 资助金额:
    $ 60.51万
  • 项目类别:
Stem cell mobilization and diabetic skin ulcers
干细胞动员和糖尿病皮肤溃疡
  • 批准号:
    8370929
  • 财政年份:
    2012
  • 资助金额:
    $ 60.51万
  • 项目类别:
Stem cell mobilization and diabetic skin ulcers
干细胞动员和糖尿病皮肤溃疡
  • 批准号:
    8731122
  • 财政年份:
    2012
  • 资助金额:
    $ 60.51万
  • 项目类别:

相似海外基金

Understanding the Heightened Amputation Risk Among People Experiencing Homelessness: A Population-based Cohort Study
了解无家可归者截肢风险升高:一项基于人群的队列研究
  • 批准号:
    480010
  • 财政年份:
    2023
  • 资助金额:
    $ 60.51万
  • 项目类别:
    Operating Grants
Collaborative Research: An Integrated, Proactive, and Ubiquitous Prosthetic Care Robot for People with Lower Limb Amputation: Sensing, Device Designing, and Control
合作研究:针对下肢截肢患者的集成、主动、无处不在的假肢护理机器人:传感、设备设计和控制
  • 批准号:
    2246672
  • 财政年份:
    2023
  • 资助金额:
    $ 60.51万
  • 项目类别:
    Standard Grant
Collaborative Research: An Integrated, Proactive, and Ubiquitous Prosthetic Care Robot for People with Lower Limb Amputation: Sensing, Device Designing, and Control
合作研究:针对下肢截肢患者的集成、主动、无处不在的假肢护理机器人:传感、设备设计和控制
  • 批准号:
    2246671
  • 财政年份:
    2023
  • 资助金额:
    $ 60.51万
  • 项目类别:
    Standard Grant
Advancing measurement of physical function in upper limb amputation
推进上肢截肢身体功能的测量
  • 批准号:
    10749083
  • 财政年份:
    2023
  • 资助金额:
    $ 60.51万
  • 项目类别:
Collaborative Research: An Integrated, Proactive, and Ubiquitous Prosthetic Care Robot for People with Lower Limb Amputation: Sensing, Device Designing, and Control
合作研究:针对下肢截肢患者的集成、主动、无处不在的假肢护理机器人:传感、设备设计和控制
  • 批准号:
    2246673
  • 财政年份:
    2023
  • 资助金额:
    $ 60.51万
  • 项目类别:
    Standard Grant
Establishing the Relationship Between Muscle Quality and Joint Loading for Individuals with Transtibial Amputation
建立小腿截肢患者的肌肉质量和关节负荷之间的关系
  • 批准号:
    10677236
  • 财政年份:
    2023
  • 资助金额:
    $ 60.51万
  • 项目类别:
Preventing Amputation through Management of Diabetic Foot; Working with Industry to generate supply chains in an LMIC setting (Uganda) for low-cost fo
通过糖尿病足管理预防截肢;
  • 批准号:
    2883969
  • 财政年份:
    2023
  • 资助金额:
    $ 60.51万
  • 项目类别:
    Studentship
Diabetes Lower Extremity Complications Research and Training Network in Foot Ulcer and Amputation Prevention (DIALECT)
糖尿病下肢并发症足部溃疡和截肢预防研究与培训网络 (DIALECT)
  • 批准号:
    EP/X02699X/1
  • 财政年份:
    2022
  • 资助金额:
    $ 60.51万
  • 项目类别:
    Research Grant
Myoelectric upper limb prosthesis with multiple degrees of freedom using targeted muscle reinnervation surgery for traumatic amputation
多自由度肌电上肢假肢,采用靶向肌肉神经支配手术治疗创伤性截肢
  • 批准号:
    22K16723
  • 财政年份:
    2022
  • 资助金额:
    $ 60.51万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
An automatically-adjusting prosthetic socket for people with transtibial amputation
适用于小腿截肢患者的自动调节假肢接受腔
  • 批准号:
    10364108
  • 财政年份:
    2022
  • 资助金额:
    $ 60.51万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了